| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/09/2007 | US20070184529 Mammalian cell culture process |
| 08/09/2007 | US20070184527 Methods for Production of Proteins |
| 08/09/2007 | US20070184522 Cell death modulation via antagonists of Fasl and Fas activation |
| 08/09/2007 | US20070184519 Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production |
| 08/09/2007 | US20070184518 Stabilized proteins |
| 08/09/2007 | US20070184517 Pharmacokinetics; glycosyltransferases; antibodies; immunoglobulins |
| 08/09/2007 | US20070184504 Assay for anti-INGAP antibodies |
| 08/09/2007 | US20070184497 Clinical diagnostic reagent and diagnostic method for testing infection of adult taenia solium and taenia saginata |
| 08/09/2007 | US20070184488 Beta-secretase substrates and uses thereof |
| 08/09/2007 | US20070184485 Method of diagnosing diseases relating to endometriosis |
| 08/09/2007 | US20070184480 C-terminal 28kDa endostatin-spanning proteolytic fragment for use in prevention and treatment of inflammation and cell proliferative disorders |
| 08/09/2007 | US20070184469 nine residue peptides (ApoptoM) from flavivirus M ectodomain able to modulate specifically the apoptotic activity of diverse flavivirus; use for the treatment and/or the prevention of flavivirus-linked infections and cancers |
| 08/09/2007 | US20070184461 Novel Polypeptide Hormone Phosphatonin |
| 08/09/2007 | US20070184452 Identification of a gene and mutation responsible for autosomal recessive congenital hydrocephalus |
| 08/09/2007 | US20070184444 Compositions and methods for the treatment of immune related diseases |
| 08/09/2007 | US20070184443 Streptococcus pneumoniae knockout mutants |
| 08/09/2007 | US20070184442 Lafora's disease gene |
| 08/09/2007 | US20070184440 Methods of screening for useful proteins |
| 08/09/2007 | US20070184074 Fusion proteins of Mycobacterium tuberculosis |
| 08/09/2007 | US20070184073 TB diagnostic based on antigens from M. tuberculosis |
| 08/09/2007 | US20070184072 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 08/09/2007 | US20070184071 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 08/09/2007 | US20070184070 Recombinant toxin fragments |
| 08/09/2007 | US20070184069 Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines |
| 08/09/2007 | US20070184065 Compositions and Methods for Inhibiting Viral Adhesion |
| 08/09/2007 | US20070184064 Chimeric peptide immunogens |
| 08/09/2007 | US20070184063 Production of Proteins Carrying Oligomannose or Human-Like Glycans in Yeast and Methods of Use Thereof |
| 08/09/2007 | US20070184062 Promotes a prolonged, directed cytotoxic T cell response to the target cell; cancer; vaccine |
| 08/09/2007 | US20070184054 polynucleotide encoding oocyst sporocyst protein (EtOs22); for finding active compounds for treating an infection with Eimeria |
| 08/09/2007 | US20070184053 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 08/09/2007 | US20070184052 Soluble tgf-b type III receptor fusion proteins |
| 08/09/2007 | US20070184042 Method of cancer treatment by p53 protein control |
| 08/09/2007 | US20070184025 Chimaeric vector system |
| 08/09/2007 | US20070184023 Method for down-regulation of vegf |
| 08/09/2007 | US20070183978 Methods and compositions for diagnosis and immunotherapy of pollen allergy |
| 08/09/2007 | US20070183977 RGD peptide sequence; labelled with fluorescein used as contrast agents in optical imaging in diagnosis of angiogenesis-related diseases; peptidic vector and the fluorescein dye are coupled; cyclic peptide forming disulife or monothioether bridge |
| 08/09/2007 | US20070183975 Polypeptide absorbable into digestive organs |
| 08/09/2007 | DE102006060375A1 New aprotinin variants, in which the amino acid lysine is interchanged against another amino acid, after the natural sequence, useful for e.g. reducing blood loss during polytrauma, shock, inflammation and cancer |
| 08/09/2007 | CA2638887A1 Methods of treating degenerative disorders with rac 1b inhibitor |
| 08/09/2007 | CA2638834A1 Method for producing epitomers and their uses on carrier microorganisms |
| 08/09/2007 | CA2638761A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor v |
| 08/09/2007 | CA2623908A1 Methods for enhancing the degradation or conversion of cellulosic material |
| 08/08/2007 | EP1816205A1 Serotype of adenovirus and uses thereof |
| 08/08/2007 | EP1816204A1 Recombinant Adenovirus of the Ad26 serotype |
| 08/08/2007 | EP1816202A2 Transgenic plants expressing DNA constructs containing a plurality of genes to impart virus resistance |
| 08/08/2007 | EP1816201A1 Modified coagulation factor VIIa with extended half-life |
| 08/08/2007 | EP1816200A1 Postweaning multisystemic wasting syndrome virus for pigs |
| 08/08/2007 | EP1816199A1 Mutants of thyroid stimulating hormone and methods based thereon |
| 08/08/2007 | EP1816196A1 La1 - The genome of a Lactobacillus strain |
| 08/08/2007 | EP1816139A1 Nact as a target for lifespan expansion and weight reduction |
| 08/08/2007 | EP1815862A1 Isolated stromal cells for use in the tretment of diseases of the central nervous system |
| 08/08/2007 | EP1814997A2 Arabidopsis and brassica nucleic acid sequences conferring lipid and sugar alterations in plants and methods of use |
| 08/08/2007 | EP1814996A2 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 08/08/2007 | EP1814992A1 Gamma-delta t cell receptors |
| 08/08/2007 | EP1814991A1 Treatment of neurodegenerative diseases by the use of laptm4a |
| 08/08/2007 | EP1814915A1 Neutralising antibody molecules having specificity for human il-17 |
| 08/08/2007 | EP1814911A2 G protein coupled receptor agonists and antagonists and methods of use |
| 08/08/2007 | EP1814910A2 Novel peptides that bind to the erythropoietin receptor |
| 08/08/2007 | EP1814909A1 Use of aimp2dx2 for the diagnosis and treatment of cancer |
| 08/08/2007 | EP1814908A1 Activated labeling reagents and methods for preparing and using the same |
| 08/08/2007 | EP1814907A2 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
| 08/08/2007 | EP1814906A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 08/08/2007 | EP1814905A1 Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest |
| 08/08/2007 | EP1814904A2 Antibiotic drosocin derivatives |
| 08/08/2007 | EP1814903A2 Leucine-rich repeat (lrr) motif containing proteins |
| 08/08/2007 | EP1814897A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 08/08/2007 | EP1814583A2 Combination approaches for generating immune responses |
| 08/08/2007 | EP1814378A2 Casein kinase stress-related polypeptides and methods of use in plants |
| 08/08/2007 | EP1723172B1 Erythropoietin liquid formulation |
| 08/08/2007 | EP1709179A4 Transgenic plants with reduced level of saturated fatty acid and methods for making them |
| 08/08/2007 | EP1636383A4 Composition for screening anti-hypertension drug comprising mammal tctp gene or its protein product, and method for screening anti-hypertension drug using said composition |
| 08/08/2007 | EP1615656B1 Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same |
| 08/08/2007 | EP1575515A4 Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor |
| 08/08/2007 | EP1575490A4 Modified glucagon-like peptide-1 analogs |
| 08/08/2007 | EP1572975A4 Streptococcus uberis adhesion molecule |
| 08/08/2007 | EP1551435A4 Method for enzymatic production of glp-1 (7-36) amide peptides |
| 08/08/2007 | EP1532142A4 Polypeptide cleavage process |
| 08/08/2007 | EP1480671B1 Recombinant rsv virus expression systems and vaccines |
| 08/08/2007 | EP1456382B1 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| 08/08/2007 | EP1451219B1 Nuclear protein "shoca" - a component of the wnt signalling pathway |
| 08/08/2007 | EP1392728B1 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
| 08/08/2007 | EP1354890B1 Chordin-like polypeptides and dna thereof |
| 08/08/2007 | EP1228226B1 Genes and methods for manipulation of growth |
| 08/08/2007 | EP1211318B1 Paramyxoviruses comprising a modified transcription start sequence |
| 08/08/2007 | EP1187852B1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS |
| 08/08/2007 | EP1157112B1 Nucleic acid and amino acid sequences of hemoglobin-response genes in candida albicans and the use of reagents derived from these sequences in the diagnosis of disseminated candida albicans infection |
| 08/08/2007 | EP1108035B1 Treatment of cervical cancer |
| 08/08/2007 | EP1100538B1 Kvlqt1 - a long qt syndrome |
| 08/08/2007 | EP1092772B1 Antibody against lar phosphatase subunit |
| 08/08/2007 | EP1082444B1 Adeno-associated virus vectors and uses thereof |
| 08/08/2007 | EP1075523B1 Structural proteins of fish pancreatic disease virus and uses thereof |
| 08/08/2007 | EP0941338B1 Methods for preparing nucleotide integrases |
| 08/08/2007 | EP0882065B1 Novel human metabotropic glutamate receptor |
| 08/08/2007 | EP0843516B1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits |
| 08/08/2007 | EP0837129B1 Epimorphin antagonist and process for producing the same |
| 08/08/2007 | EP0812331B2 Mhc-antigen complexes for detecting and purifying antigen-specific t cells |
| 08/08/2007 | EP0807173B1 Methods for producing immunoglobulins containing protection proteins in plants and their use |
| 08/08/2007 | EP0706376B2 Anti-angiogenic compositions and methods of use |
| 08/08/2007 | CN1330765C Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 08/08/2007 | CN1330758C Antifungal polypeptide and its preparation method |